Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIb, Double-blind, Randomised, Placebo-controlled, Multi-centre, Dose-finding Efficacy and Safety Study of a Range of Doses of Elobixibat in Patients With Chronic Idiopathic Constipation

NCT01007123 is registered in ClinicalTrials.gov with Albireo as lead sponsor.

NCT NCT01007123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01007123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIb, Double-blind, Randomised, Placebo-controlled, Multi-centre, Dose-finding Efficacy and Safety Study of a Range of Doses of Elobixibat in Patients With Chronic Idiopathic Constipation
Lead sponsor
Albireo
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2009
Completion date
October 31, 2010
Enrollment
190 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

chronic constipation, constipation